AF ChemPharm

AF ChemPharm

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

AF ChemPharm is a private, revenue-generating chemistry services CRO founded in 2005 and based in Sheffield, UK. The company leverages a team of PhD chemists and a distinguished scientific advisory board to offer custom synthesis, contract research, and consultancy, accelerating drug discovery projects for global clients. Its core value proposition is acting as an extension of a client's research team, de-risking and accelerating R&D through high-quality, rapid-turnaround chemistry services. While primarily a service provider, it has also engaged in internal research programs, such as developing a new generation of antibiotics.

Small MoleculesDrug Delivery

Technology Platform

Integrated chemistry services platform leveraging a team of PhD synthetic/organometallic chemists, a distinguished academic Scientific Advisory Board, and state-of-the-art labs with kilo-scale and analytical capabilities for custom synthesis and contract R&D.

Opportunities

The growing trend of pharmaceutical and biotech R&D outsourcing provides a steady demand for high-quality chemistry services.
The company's internal antibiotic program, backed by regional grants, represents an opportunity to generate proprietary IP and transition toward a hybrid service/development model.
Its scale-up capabilities position it to capture work in the early clinical supply chain.

Risk Factors

Intense competition in the chemistry CRO market pressures pricing and requires constant innovation.
The business is reliant on attracting and retaining scarce PhD-level chemistry talent.
Revenue is subject to cyclicality based on client R&D budgets and the financial health of the biotech sector.

Competitive Landscape

AF ChemPharm competes in a fragmented global market for chemistry CRO services, ranging from large, full-service CROs (e.g., Charles River, Labcorp, Evotec) to numerous small, niche providers. Its differentiation lies in its deep academic ties, focused expertise in complex organic synthesis, and flexible, client-centric approach, but it faces constant pressure on cost and speed from all competitors.